Kairus Dadachanji entered the pharmaceutical industry providing tubular glass primary packaging for injectables.
Kaisha Lifesciences was established under the Dadachanji Group of Companies in Mumbai, India as a young and innovative pharmaceutical company providing safe, effective, quality medical products.
Kaisha Lifesciences became fully operational, continuing to build its own drug pipeline as well as engaging in contract R&D services for its customers.
DSIR Approval Received for Kaisha Lifesciences.
First Indian Patent Approval for Kaisha Lifesciences.
As a research oriented, privately-owned Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products across the globe, Kaisha Lifesciences is committed to the highest levels of quality meeting the exemplary standards of an international pharmaceutical company.
Its philosophy of 'One Quality for All' helps maintain the highest standards for all its products, which are developed and manufactured under the tightest controls to ensure patient safety. Kaisha Lifesciences prides itself on instilling the fundamental value of quality in all its employees, which reinforces its commitment to all its customers.
Ondansetron Injection, Diclofenac Sodium Injection, Enoxaparin Sodium Injection and more
Dedicated departments for Formulation Development, Analytical Development, Quality Assurance and Regulatory Affairs.